LON:DEST Destiny Pharma (DEST) Share Price, News & Analysis → A new way to collect income from stocks (From DTI) (Ad) Free DEST Stock Alerts GBX 22.12 -0.88 (-3.80%) (As of 02:16 PM ET) Add Compare Share Share Today's Range 21.68▼ 23.5050-Day Range 17.50▼ 4652-Week Range 16.50▼ 84Volume190,540 shsAverage Volume418,856 shsMarket Capitalization£21.09 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades Get Destiny Pharma alerts: Email Address Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry About Destiny Pharma Stock (LON:DEST)Destiny Pharma plc, a biotechnology company, focuses on the discovery, development, and commercialization of novel medicines to prevent serious infections in the United Kingdom. The company is involved in developing NTCD-M3 that is in Phase II clinical trial for the prevention of recurrent Clostridioides diffcile infections; XF-73 Nasal, which is in Phase II clinical trial for the prevention of post-surgical staphylococcal infection; and XF-73 Dermal that is in preclinical stage for the treatment of skin infections of antibiotic resistant bacteria, as well as superficial skin infections of antibiotic resistant bacteria. It also develops SPOR-COV, biotherapeutic product, which is in preclinical stage for the prevention of COVID-19 and other viral respiratory infections; and XF Drugs Research/Biofilms that is in preclinical stage for the treatment of antibiotic resistant biofilm and bacterial aggregate associated infections. In addition, the company is involved in the development of XF drugs for the treatment of respiratory, dermal, oral and ocular infections. Destiny Pharma plc has collaboration agreements with China Medical System Holdings Limited; SporeGen Limited; Sebela Pharmaceuticals; the University of Southampton; Aston University; the University of Sheffield; National Biofilms Innovation Centre; National Institute of Allergy and Infectious Diseases; Cystic Fibrosis Foundation; Cardiff University; and Tianjin Medical University. The company was incorporated in 1996 and is based in Brighton, the United Kingdom.Read More DEST Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DEST Stock News HeadlinesApril 8, 2024 | usatoday.comCarol Ann Langford’s Legacy of Servant Leadership Informs Her Mission to Nurture Human InnovationApril 3, 2024 | msn.comMarcelo Weigandt opens up on Messi, Maradona, Inter Miami and why he wears No. 57April 23, 2024 | DTI (Ad)I have a unique way to “hijack” the stock market.I have a unique way to “hijack” the stock market. And it’s not a matter of picking the next, big Amazon-like stock… Or guessing on the next A.I. moonshot like NVDA… This is not as hard as making amazing predictions like those.March 28, 2024 | msn.com'Lefties losing it': Dr Jordan Peterson gives 'masterclass in lefty annihilation'March 20, 2024 | nytimes.comOprah, Ozempic and UsMarch 18, 2024 | bizjournals.comNKU College of Law, UK College of Medicine plan $150M riverfront facility in CovingtonMarch 16, 2024 | msn.comHolding up half the skyMarch 15, 2024 | msn.comIndia Mobilizes Aid Amid Haiti’s Gang Violence: 24-Hour Helpline and Evacuation Plans in MotionApril 23, 2024 | The Bull Report (Ad)Healthcare Takes A Big Step Forward With The Help Of AIThe average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.March 12, 2024 | msn.comRBI goes after ‘peer to peer’ transactions – Cred, NoBroker on radarMarch 11, 2024 | msn.comUR's New Vaccinology Programme Is a Step in the Right DirectionMarch 8, 2024 | abcnews.go.com'I believe in America': Fired-up Biden uses State of the Union to skewer GOP, his 'predecessor'March 8, 2024 | nytimes.comAn Instant Crush Over Mashed PotatoesMarch 6, 2024 | bizjournals.comBayer CEO on how he plans to fix a 'broken' companyFebruary 23, 2024 | dailymail.co.ukITV orders a drama depicting the contaminated blood scandal after Mr Bates Vs The Post Office sparked nationwide uproarFebruary 22, 2024 | morningstar.comDestiny Pharma PLC DESTFebruary 19, 2024 | msn.comHow George Washington can save Israel, and NetanyahuFebruary 18, 2024 | msn.comRFK Jr. has a distinct appeal when it comes to young male votersFebruary 9, 2024 | benzinga.comDestiny Pharma Stock (OTC:DTTYF), Analyst Ratings, Price Targets, PredictionsFebruary 6, 2024 | msn.comHarsh Goenka's vision: India needs to rediscover and recover its old mojoFebruary 4, 2024 | msn.comWant to live forever? The longevity doctor will see you now…February 2, 2024 | msn.comIs it safe to take the weight-loss drug Wegovy for years or maybe forever? Doctors weigh inJanuary 31, 2024 | lse.co.ukDestiny Pharma. Share ChatJanuary 11, 2024 | msn.comBethesda’s Indiana Jones Game May Finally Have A NameJanuary 8, 2024 | msn.comSMALL CAPS IDEAS: Race to diffuse $1trillion healthcare timebombJanuary 8, 2024 | msn.comSMALL CAPS IDEA: Destiny Pharma playing its part in the race to diffuse deadly $1trillion healthcare timebombJanuary 6, 2024 | msn.comIn honor of public servants: The case for making Jan. 6 a national holidaySee More Headlines Receive DEST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Destiny Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings9/17/2020Today4/22/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:DEST CUSIPN/A CIKN/A Webwww.destinypharma.com Phone+44-1273-704440FaxN/AEmployees24Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-5,970,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-52.87% Return on Assets-36.69% Debt Debt-to-Equity RatioN/A Current Ratio9.48 Quick Ratio11.10 Sales & Book Value Annual Sales£135,028.00 Price / Sales162.35 Cash FlowGBX 8.55 per share Price / Cash Flow2.69 Book ValueGBX 14 per share Price / Book1.64Miscellaneous Outstanding Shares95,310,000Free FloatN/AMarket Cap£21.92 million OptionableNot Optionable Beta0.27 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesDr. William Guy Love (Age 62)Founder, Chief Scientific Officer & Director Comp: $265kMr. Shaun Claydon ACA (Age 56)CFO, Company Secretary & Director Comp: $286kDr. Debra Barker M.D. (Age 62)MSc., Interim CMO & Senior Independent Director Comp: $41kMr. Christopher John Tovey BSc (Age 59)CEO & Director Key CompetitorsOptiBiotix HealthLON:OPTIOxford BioDynamicsLON:OBDOncimmuneLON:ONCSkinBioTherapeuticsLON:SBTXOndine BiomedicalLON:OBIView All CompetitorsInsidersNick RodgersBought 49,477 shares on 5/25/2023Total: £1.53 M ($31.00/share)View All Insider Transactions DEST Stock Analysis - Frequently Asked Questions How have DEST shares performed in 2024? Destiny Pharma's stock was trading at GBX 70 at the beginning of 2024. Since then, DEST stock has decreased by 68.4% and is now trading at GBX 22.13. View the best growth stocks for 2024 here. How were Destiny Pharma's earnings last quarter? Destiny Pharma plc (LON:DEST) released its quarterly earnings results on Thursday, September, 17th. The company reported ($5.50) EPS for the quarter. What other stocks do shareholders of Destiny Pharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other Destiny Pharma investors own include Dynavax Technologies (DVAX), AFPO.L (AFPO), Aldeyra Therapeutics (ALDX), Ares Capital (ARCC), BioCryst Pharmaceuticals (BCRX), BioNTech (BNTX), Centamin (CEY), Countryside Partnerships (CSP), Enbridge (ENB) and EQTEC (EQT). How do I buy shares of Destiny Pharma? Shares of DEST stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:DEST) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishingtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Destiny Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
